Translational Drug Development - Ownership and Business Overview

Business ServicesCompany

Translational Drug Development Ownership

Who owns Translational Drug Development?

Translational Drug Development is owned by Research Technologies. It was acquired on June 4, 2020.

Translational Drug Development Business Overview

Where is Translational Drug Development headquartered?

Translational Drug Development is headquartered in Scottsdale, Arizona.

What sector is Translational Drug Development in?

Translational Drug Development is a business services company.

When was Translational Drug Development founded?

Translational Drug Development was founded in 2003.

Business Services M&A Summary in 2020

Out of 60 sectors in the Mergr database, business services ranked 2 in number of deals in 2020. The largest business services acquisition in 2020 was Hms Holdings - which was acquired by Gainwell Technologies for $3.4B.

Join Mergr to view all 810 acquisitions of business services companies in 2020, including 136 acquisitions by private equity firms, and 674 by strategics.

Translational Drug Development LLC

13208 E. Shea Blvd., Suite 100,
Scottsdale, Arizona 85259
United States,
(602) 358 8300
www.td2inc.com

Translational Drug Development LLC provides end-to-end solutions, including translational preclinical services; regulatory strategic guidance, planning and document submission services; and clinical trial design and execution for innovative oncology-focused companies. Translational Drug Development was founded in 2003 is based in Scottsdale, Arizona.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.